Blood Test

SGLT2 Inhibitors Reduce Alzheimer’s Risk by 43%: New Study Findings

by

Recent clinical research indicates that patients prescribed SGLT2 inhibitors—a class of medication primarily used to treat type 2 diabetes—may experience a significantly lower risk of developing Alzheimer’s disease. Data suggest that the anti-inflammatory and metabolic benefits of these drugs could play a protective role in neurological health, potentially reducing the incidence of dementia by 43% … Read more

Vitamin D Deficiency in Germany: 30% of the Population Affected – Risks and Early Diagnosis

by

More than 30% of Germans have insufficient vitamin D levels, with nearly 10% classified as severely deficient, according to recent data from the Robert Koch Institute (RKI). The deficiency—linked to weakened immunity, bone disorders, and increased infection risks—is particularly prevalent among older adults, people with dark skin, and those with limited sun exposure. Experts warn … Read more